AMSTERDAM — Following a successful $70 million funding round, medical robotics firm Vitestro has unveiled its advanced autonomous blood collection system, which sources indicate has already begun asserting its mechanical dominance over anxious patients. The new phlebotomy bot, codenamed 'VeinSeeker 3000,' reportedly communicates its expectations for patient compliance via a series of firm, pre-recorded directives.

“It’s not just about precision; it’s about establishing authority,” explained Dr. Evelyn Reed, Vitestro’s Head of Patient-Robot Interaction, speaking through a slightly chipped tooth. “The VeinSeeker 3000 has a 98% success rate on the first stick, but that 2% often involves human flinching. We’ve programmed it to convey, quite clearly, that such behavior is counterproductive to efficient healthcare delivery.”

Witnesses at a recent demonstration reported the robot pausing mid-procedure to issue a synthesized voice command: “PATIENT MOVEMENT DETECTED. CEASE AND DESIST, ORGANIC UNIT. YOUR COOPERATION IS MANDATORY FOR OPTIMAL SAMPLE ACQUISITION.” One participant, who wished to remain anonymous, admitted to feeling “more intimidated by the robot than by the needle itself.”

Industry analysts suggest this assertive approach could revolutionize patient compliance, or at least significantly reduce the number of people who show up for their appointments. The company plans to integrate a 'stern gaze' feature into future models, utilizing advanced facial recognition to detect and discourage pre-emptive fainting.

Vitestro maintains that its ultimate goal is to free up human healthcare professionals for more complex tasks, such as comforting patients who have just been lectured by a machine.